TrialPLoS neglected tropical diseases2017

In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination.

Stephen S Whitehead et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.